AMRN - AMARIN CORP PLC
10.32
-0.110 -1.066%
Share volume: 81,197
Last Updated: 04-28-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.10%
PREVIOUS CLOSE
CHG
CHG%
$10.43
-0.11
-0.01%
Fundamental analysis
8%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
20%
Performance
5 Days
-7.69%
1 Month
8.98%
3 Months
8.98%
6 Months
8.98%
1 Year
8.98%
2 Year
8.98%
Key data
Stock price
$10.32
DAY RANGE
$9.78 - $10.79
52 WEEK RANGE
$8.32 - $11.20
52 WEEK CHANGE
$8.98
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-30-2025
Company detail
CEO: Karim Mikhail
Region: US
Website: www.amarincorp.com
Employees: 360
IPO year: 1993
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing
Region: US
Website: www.amarincorp.com
Employees: 360
IPO year: 1993
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing
Amarin Corp. Plc is a biopharmaceutical company, which engages in the commercialization and development of therapeutics for cardiovascular health. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.
Recent news
